Olumiant 2mg Tablet

Olumiant 2mg Tablet

Olumiant 2mg Tablet contains Baricitinib 2mg, an oral Janus kinase (JAK) inhibitor manufactured by Eli Lilly used to manage moderate to severe rheumatoid arthritis in adults. It works by selectively blocking JAK1 and JAK2 enzymes involved in the signaling pathways that drive joint inflammation, offering an effective oral alternative for patients who have not responded adequately to conventional DMARDs.

Key Features

• Contains Baricitinib 2mg, a targeted oral JAK1/JAK2 inhibitor
• Manages moderate to severe rheumatoid arthritis in adults
• Reduces joint inflammation, pain and morning stiffness
• Convenient once-daily oral tablet, no injections required
• Trusted formulation from Eli Lilly
• Strip of 10 tablets

Key Ingredients

• Baricitinib 2mg

Uses

Prescribed for the management of rheumatoid arthritis and related inflammatory conditions as directed by a physician or specialist. It may be used alone or in combination with methotrexate or other conventional DMARDs as part of a comprehensive rheumatoid arthritis treatment plan.

Directions for Use

Take exactly as prescribed by your physician, typically once daily, with or without food, at the same time each day for consistent results.

Precautions

• Use only as prescribed by a registered physician/specialist
• Regular blood tests to monitor liver function, blood counts, and cholesterol levels are typically required during treatment.
• Inform your doctor of any existing conditions, infections, or allergies before starting treatment
• Keep away from children

Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only. This is a prescription medication; use only under medical supervision.